Boardroom Alpha
Boardroom Alpha
CVM · Current Report (Form 8-K) · Filed August 17, 2026

Cel Sci Corp — Current Report (Form 8-K)

Form
8-K
Filed
August 17, 2026
Period
Aug 14, 2026
Ticker
CVM
Accession
0001654954-26-007691
Boardroom Alpha · Filing insights

CEL-SCI elected three directors and approved key governance actions, including 2026 stock plans, executive compensation, and auditor appointment.

About Cel Sci Corp
Market cap
$26M
1Y TSR
−84.3%
3Y TSR
−67.5%
Board grade
D
Sector
Healthcare
CEO
Geert R Kersten
Last annual meeting: Aug 14, 2026 · View full Cel Sci Corp profile →
cvm_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (date of earliest event reported): August 14, 2026

 

CEL-SCI CORPORATION

(Exact name of Registrant as specified in its charter)

 

 

Colorado

 

001-11889

 

84-0916344

(State or other jurisdiction

of incorporation)

 

(Commission

File No.)

 

(IRS Employer

Identification No.)

 

8229 Boone Blvd. #802

Vienna, VA 22182

 

(Address of principal executive offices, including Zip Code)

 

Registrant’s telephone number, including area code: (703) 506-9460

 

N/A

(Former name or former address if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading Symbol(s)

 

Name of Each Exchange on Which Registered

Common Stock, par value $0.01 per share

 

CVM

 

NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§203.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§204.12b-2 of this chapter.

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 5.07. Submission of Matters to a Vote of Securities Holders.

 

The annual meeting of CEL-SCI’s shareholders was held on August 14, 2026. At the meeting the following persons were elected as directors for the upcoming year:

 

Name

Votes For

Votes Withheld

Broker Non-Votes

Geert Kersten

4,371,909

   478,675

4,365,596

Bruno Baillavoine

2,188,254

2,662,330

4,365,596

Robert Watson

2,062,150

2,788,434

4,365,596

 

At the meeting the following were approved by CEL-SCI’s shareholders:

 

 

(2)

the adoption of CEL-SCI’s 2026 Non-Qualified Stock Option Plan; and

 

 

 

 

(3)

the adoption of CEL-SCI’s 2026 Stock Bonus Plan;

 

 

 

 

(4)

to approve, on a non-binding advisory basis, the compensation of CEL-SCI’s executive officers;

 

 

 

 

(5)

to approve, on a non-binding advisory basis, the frequency of the advisory vote regarding the compensation of CEL-SCI’s executive officers; and

 

 

 

 

(6)

to ratify the appointment of BDO USA, LLP as CEL-SCI’s independent registered public accounting firm for the fiscal year ending September 30, 2026; and

 

The following is a tabulation of votes cast with respect to proposals 2, 3, 4 and 6:

 

Proposal

Votes For

Votes Against

Abstain

Broker Non-Votes

(2)

3,654,395

1,144,219

   51,970

4,365,596

(3)

3,793,843

    997,808

   58,933

4,365,596

(4)

3,777,031

1,010,124

   63,429

4,365,596

(6)

8,638,163

364,150

213,867

0

 

The following is a tabulation of votes cast with respect to proposals 5:

 

Proposal

1 Year

2 Years

3 Years

Abstain

Broker

Non-Votes

(5)

1,692,789

158,296

2,668,661

330,838

4,365,596

 

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 Date:  August 17, 2026   CEL-SCI CORPORATION
    
By:/s/ Geert Kersten

 

 

Geert Kersten 
  Chief Executive Officer 

 

 

3

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Cel Sci Corp (CVM)

Reference

Frequently asked questions

When did Cel Sci Corp file this 8-K?
Cel Sci Corp (CVM) filed this Current Report (Form 8-K) with the SEC on August 17, 2026. The accession number assigned by EDGAR is 0001654954-26-007691.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
CEL-SCI elected three directors and approved key governance actions, including 2026 stock plans, executive compensation, and auditor appointment. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Cel Sci Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Cel Sci Corp has filed under CIK 725363, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer